US EditionThe Export-Import Bank of Korea Will Provide 350 Billion Won in Support for the Acquisition of Celltrion's Us Production Facility.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
This financial support will help establish a comprehensive production and sales system in the US, the world's largest pharmaceutical market. The Export-Import Bank of Korea operates a "Preferential Support Program for Advanced Strategic Industries" to support K-Bio's global competitiveness. [Digital Daily Reporter Park Ki-rok] The Export-Import Bank of Korea announced on the 25th that it will provide 350 billion won in financing for Celltrion's …
Celltrion receives $240 million from Korea Eximbank
Pictured above is the head office of Korea EXIMbank in Seoul. [Photo courtesy of Korea EXIMbank] The Export–Import Bank of Korea (Korea Eximbank) announced on the 25th that it would provide 350 billion won ($240 million) in financing to support Celltrion’s acquisition of a U.S. manufacturing facility owned by Eli Lilly. Through this financial backing, Celltrion would be able to establish an integrated production and sales system within the Unite…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
